MedKoo Cat#: 326715 | Name: Tenatoprazole
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tenatoprazole, also known as TU-199, is a proton pump inhibitor drug candidate that was undergoing clinical testing as a potential treatment for reflux oesophagitis and peptic ulcer. Tenatoprazole has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors, and has a half-life about seven times longer than other PPIs.

Chemical Structure

Tenatoprazole
Tenatoprazole
CAS#113712-98-4

Theoretical Analysis

MedKoo Cat#: 326715

Name: Tenatoprazole

CAS#: 113712-98-4

Chemical Formula: C16H18N4O3S

Exact Mass: 346.1100

Molecular Weight: 346.41

Elemental Analysis: C, 55.48; H, 5.24; N, 16.17; O, 13.86; S, 9.26

Price and Availability

Size Price Availability Quantity
50mg USD 190.00
100mg USD 350.00
200mg USD 650.00
500mg USD 1,050.00
1g USD 1,750.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
TU-199; TU 199; TU199; Tenatoprazole; Ulsacare; Protop.
IUPAC/Chemical Name
5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine
InChi Key
ZBFDAUIVDSSISP-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H18N4O3S/c1-9-7-17-12(10(2)14(9)23-4)8-24(21)16-18-11-5-6-13(22-3)19-15(11)20-16/h5-7H,8H2,1-4H3,(H,18,19,20)
SMILES Code
O=S(C1=NC2=NC(OC)=CC=C2N1)CC3=NC=C(C)C(OC)=C3C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 346.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Long K, Guan J, Yu J, Zhang D, Shi S. Preparation and study of a capillary electrochromatographic column prepared by conjugating β-CD COFs and gold-poly glycidyl methacrylate nanoparticles. Mikrochim Acta. 2024 Jul 9;191(8):457. doi: 10.1007/s00604-024-06533-8. PMID: 38980449. 2: Zou S, Ouyang M, Cheng Q, Shi X, Sun M. Acid-suppressive drugs: A systematic review and network meta-analysis of their nocturnal acid-inhibitory effect. Pharmacotherapy. 2024 Feb;44(2):171-183. doi: 10.1002/phar.2899. Epub 2023 Dec 12. PMID: 38049205. 3: Huo H, Guan J, Huang Z, Long K, Zhang D, Shi S, Yan F. Preparation of β-cyclodextrin covalent organic framework-immobilized poly(glycidyl methacrylate) nanoparticle-coated open tubular capillary electrochromatography column for chiral separation. J Sep Sci. 2023 Jul;46(14):e2300117. doi: 10.1002/jssc.202300117. Epub 2023 May 28. PMID: 37246276. 4: Cheff DM, Cheng Q, Guo H, Travers J, Klumpp-Thomas C, Shen M, Arnér ESJ, Hall MD. Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4. Redox Biol. 2023 Jul;63:102719. doi: 10.1016/j.redox.2023.102719. Epub 2023 May 16. PMID: 37244126; PMCID: PMC10220285. 5: Le TK, Park YJ, Cha GS, Oktavia FARH, Kim DH, Yun CH. Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism. Pharmaceutics. 2022 Dec 21;15(1):23. doi: 10.3390/pharmaceutics15010023. PMID: 36678652; PMCID: PMC9863764. 6: Gu L, Guan J, Huang Z, Huo H, Shi S, Zhang D, Yan F. β-Cyclodextrin covalent organic framework supported by polydopamine as stationary phases for electrochromatographic enantioseparation. Electrophoresis. 2022 Jul;43(13-14):1446-1454. doi: 10.1002/elps.202200029. Epub 2022 Apr 28. PMID: 35353923. 7: Sui X, Guan J, Li X, Gu L, Yan F, Shi S, Zhang D. Preparation of a polydopamine/β-cyclodextrin coated open tubular capillary electrochromatography column and application for enantioseparation of five proton pump inhibitors. J Sep Sci. 2021 Sep;44(17):3295-3304. doi: 10.1002/jssc.202100298. Epub 2021 Jul 11. PMID: 34185396. 8: Papp LA, Hancu G, Kelemen H, Tóth G. Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview. Electrophoresis. 2021 Sep;42(17-18):1761-1789. doi: 10.1002/elps.202100032. Epub 2021 May 27. PMID: 34004039. 9: Young KZ, Cartee NMP, Lee SJ, Keep SG, Ivanova MI, Wang MM. Electrophilic and Drug-Induced Stimulation of NOTCH3 N-terminal Fragment Oligomerization in Cerebrovascular Pathology. Transl Stroke Res. 2021 Dec;12(6):1081-1092. doi: 10.1007/s12975-021-00908-2. Epub 2021 May 3. PMID: 33939102; PMCID: PMC8557116. 10: Mannemuddhu SS, Xu H, Bleck CKE, Tjandra N, Carter C, Bhaduri-McIntosh S. Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency. J Virol. 2021 Jun 10;95(13):e0246620. doi: 10.1128/JVI.02466-20. Epub 2021 Jun 10. PMID: 33853959; PMCID: PMC8437351. 11: Leis J, Luan CH, Audia JE, Dunne SF, Heath CM. Ilaprazole and other novel prazole-based compounds that bind Tsg101 inhibit viral budding of HSV-1/2 and HIV from cells. J Virol. 2021 May 10;95(11):e00190-21. doi: 10.1128/JVI.00190-21. Epub 2021 Mar 17. PMID: 33731460; PMCID: PMC8139698. 12: Cheng T, Liu BF, Han TY, Gu ZH, Pan P, Yu H. Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis. Medicine (Baltimore). 2021 Feb 26;100(8):e24808. doi: 10.1097/MD.0000000000024808. PMID: 33663099; PMCID: PMC7909174. 13: Pérez-Villanueva J, Yépez-Mulia L, Rodríguez-Villar K, Cortés-Benítez F, Palacios-Espinosa JF, Soria-Arteche O. The giardicidal activity of lobendazole, fabomotizole, tenatoprazole and ipriflavone: A ligand-based virtual screening and in vitro study. Eur J Med Chem. 2021 Feb 5;211:113110. doi: 10.1016/j.ejmech.2020.113110. Epub 2020 Dec 17. PMID: 33360795. 14: Cartee NMP, Wang MM. Binding of omeprazole to protein targets identified by monoclonal antibodies. PLoS One. 2020 Sep 18;15(9):e0239464. doi: 10.1371/journal.pone.0239464. PMID: 32946534; PMCID: PMC7500594. 15: Leandro J, Khamrui S, Wang H, Suebsuwong C, Nemeria NS, Huynh K, Moustakim M, Secor C, Wang M, Dodatko T, Stauffer B, Wilson CG, Yu C, Arkin MR, Jordan F, Sanchez R, DeVita RJ, Lazarus MB, Houten SM. Inhibition and Crystal Structure of the Human DHTKD1-Thiamin Diphosphate Complex. ACS Chem Biol. 2020 Aug 21;15(8):2041-2047. doi: 10.1021/acschembio.0c00114. Epub 2020 Jul 9. PMID: 32633484; PMCID: PMC7890914. 16: Escoffier J, Arnaud B, Kaba M, Hograindleur JP, Le Blévec E, Martinez G, Stévant I, Ray PF, Arnoult C, Nef S. Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro. Andrology. 2020 Nov;8(6):1795-1804. doi: 10.1111/andr.12855. Epub 2020 Jul 16. PMID: 32609951. 17: Kumar R, Kumar A, Nordberg A, Långström B, Darreh-Shori T. Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme-A plausible missing link for their association with incidence of dementia. Alzheimers Dement. 2020 Jul;16(7):1031-1042. doi: 10.1002/alz.12113. Epub 2020 May 8. PMID: 32383816. 18: Joshi AA, Nerkar PP. Determination of Proton Pump Inhibitors by Spectrophotometric, Chromatographic and by Hyphenated Techniques: A Review. Crit Rev Anal Chem. 2021;51(6):527-548. doi: 10.1080/10408347.2020.1750339. Epub 2020 Apr 20. PMID: 32312104. 19: Watanabe SM, Ehrlich LS, Strickland M, Li X, Soloveva V, Goff AJ, Stauft CB, Bhaduri-McIntosh S, Tjandra N, Carter C. Selective Targeting of Virus Replication by Proton Pump Inhibitors. Sci Rep. 2020 Mar 4;10(1):4003. doi: 10.1038/s41598-020-60544-y. PMID: 32132561; PMCID: PMC7055211. 20: Hunt RH, Scarpignato C. Potent Acid Suppression with PPIs and P-CABs: What's New? Curr Treat Options Gastroenterol. 2018 Dec;16(4):570-590. doi: 10.1007/s11938-018-0206-y. PMID: 30361857.